Lobular carcinoma, not only a classic

Breast Journal

Volumn 16, Issue SUPPL. 1, 2010, Pages

  Brogi, Edi ^a   Murray, Melissa P ^a   Corben, Adriana D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

atypical lobular hyperplasia; core biopsy; florid LCIS; LCIS with comedonecrosis; pleomorphic lobular carcinoma

Indexed keywords

UVOMORULIN;

ACINAR CELL; ATYPICAL LOBULAR HYPERPLASIA; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOMA; CHROMOSOME 16P; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 22Q; CHROMOSOME 6Q; CHROMOSOME DELETION; FOLLOW UP; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; INVASIVE PLEOMORPHIC LOBULAR CARCINOMA; LOBULAR CARCINOMA IN SITU; MAMMOGRAPHY; REVIEW;

BREAST NEOPLASMS; CADHERINS; CARCINOMA, LOBULAR; CHROMOSOME ABERRATIONS; FEMALE; HUMANS;

EID: 78649302014     PISSN: 1075122X     EISSN: 15244741     Source Type: Journal    
DOI: 10.1111/j.1524-4741.2010.00994.x     Document Type: Review

References (48)

1. Foote FW, Stewart FW,. Lobular carcinoma in situ: a rare form of mammary cancer. Am J Pathol 1941; 17: 491 -6 3. PMCID: 1965212.
2. Haagensen CD, Lane N, Lattes R, Bodian C,. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737 -69.
3. Page DL, Kidd TE, Jr, Dupont WD, Simpson JF, Rogers LW,. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 1991; 22: 1232 -9.
4. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818 -21.
5. Reis-Filho JS, Lakhani SR,. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003; 5: 313 -9.
6. Reis-Filho JS, Milanezi F, Carvalho S, et al. Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysis. Breast Cancer Res 2005; 7: R1028 -35.
7. Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM,. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 1998; 58: 4721 -7.
8. Nishizaki T, Chew K, Chu L, et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997; 74: 513 -7.
9. Gunther K, Merkelbach-Bruse S, Amo-Takyi BK, Handt S, Schroder W, Tietze L,. Differences in genetic alterations between primary lobular and ductal breast cancers detected by comparative genomic hybridization. J Pathol 2001; 193: 40 -7.
10. Etzell JE, Devries S, Chew K, et al. Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol 2001; 32: 292 -6.
11. Hwang ES, Nyante SJ, Yi Chen Y, et al. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer 2004; 100: 2562 -72.
12. Nayar R, Zhuang Z, Merino MJ, Silverberg SG,. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Hum Pathol 1997; 28: 277 -82.
13. Lakhani SR, Collins N, Sloane JP, Stratton MR,. Loss of heterozygosity in lobular carcinoma in situ of the breast. Clin Mol Pathol 1995; 48: M74 -8. PMCID: 407928.
14. Abdel-Fatah TM, Powe DG, Hodi Z, Lee AH, Reis-Filho JS, Ellis IO,. High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 2007; 31: 417 -26.
15. Abdel-Fatah TM, Powe DG, Hodi Z, Reis-Filho JS, Lee AH, Ellis IO,. Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 2008; 32: 513 -23.
16. Vos CB, Cleton-Jansen AM, Berx G, De Leeuw WJ, Ter Haar NT, Van Roy F, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997; 76: 1131 -3. PMCID: 2228132.
17. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ,. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001; 115: 85 -98.
18. Moll R, Mitze M, Frixen UH, Birchmeier W,. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Am J Pathol 1993; 143: 1731 -42. PMCID: 1887260.
19. Harigopal M, Shin SJ, Murray MP, Tickoo SK, Brogi E, Rosen PP, Aberrant E-cadherin staining patterns in invasive mammary carcinoma. World J Surg Oncol 2005; 3:73. PMCID: 1308872.
20. Da Silva L, Parry S, Reid L, et al. Aberrant expression of E-cadherin in lobular carcinomas of the breast. Am J Surg Pathol 2008; 32: 773 -83.
21. Dabbs DJ, Bhargava R, Chivukula M,. Lobular versus ductal breast neoplasms: the diagnostic utility of p120 catenin. Am J Surg Pathol 2007; 31: 427 -37.
22. Bratthauer GL, Miettinen M, Tavassoli FA,. Cytokeratin immunoreactivity in lobular intraepithelial neoplasia. J Histochem Cytochem 2003; 51: 1527 -31.
23. Lehr HA, Folpe A, Yaziji H, Kommoss F, Gown AM,. Cytokeratin 8 immunostaining pattern and E-cadherin expression distinguish lobular from ductal breast carcinoma. Am J Clin Pathol 2000; 114: 190 -6.
24. Mohsin SK, O'Connell P, Allred DC, Libby AL,. Biomarker profile and genetic abnormalities in lobular carcinoma in situ. Breast Cancer Res Treat 2005; 90: 249 -56.
25. Rudas M, Neumayer R, Gnant MF, Mittelbock M, Jakesz R, Reiner A,. p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Eur J Cancer 1997; 33: 39 -44.
26. Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N,. Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer 2004; 100: 238 -44.
27. Ottesen GL, Graversen HP, Blichert-Toft M, Christensen IJ, Andersen JA,. Carcinoma in situ of the female breast. 10?year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000; 62: 197 -210.
28. Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD, Jr, Simpson JF,. Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003; 361: 125 -9.
29. Morandi L, Marucci G, Foschini MP, et al. Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast. Virchows Arch 2006; 449: 14 -23.
30. Cangiarella J, Guth A, Axelrod D, et al. Is surgical excision necessary for the management of atypical lobular hyperplasia and lobular carcinoma in situ diagnosed on core needle biopsy?: a report of 38 cases and review of the literature. Arch Pathol Lab Med 2008; 132: 979 -83.
31. Elsheikh TM, Silverman JF,. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 2005; 29: 534 -43.
32. Shin SJ, Rosen PP,. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 2002; 126: 697 -701.
33. Nagi CS, O'Donnell JE, Tismenetsky M, Bleiweiss IJ, Jaffer SM,. Lobular neoplasia on core needle biopsy does not require excision. Cancer 2008; 112: 2152 -8.
34. Subhawong AP, Subhawong TK, Khouri N, Tsangaris T, Nassar H,. Incidental minimal atypical lobular hyperplasia on core needle biopsy: correlation with findings on follow-up excision. Am J Surg Pathol 2010; 34: 822 -28.
35. Abner AL, Connolly JL, Recht A, et al. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 2000; 88: 1072 -7.
36. Sasson AR, Fowble B, Hanlon AL, et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 2001; 91: 1862 -9.
37. Jolly S, Kestin LL, Goldstein NS, Vicini FA,. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2006; 66: 365 -71.
38. Rudloff U, Brogi E, Brockway JP, et al. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer 2009; 115: 1203 -14.
39. Collins LC, Schnitt SJ, Achacoso N, et al. Outcome of women with ductal carcinoma in situ (DCIS) and concurrent lobular neoplasia treated with breast conserving therapy: a case-control study of 657 patients from the cancer research network. Mod Pathol 2010; 23: 41A -2A.
40. Fadare O, Dadmanesh F, Alvarado-Cabrero I, et al. Lobular intraepithelial neoplasia [lobular carcinoma in situ] with comedo-type necrosis: a clinicopathologic study of 18 cases. Am J Surg Pathol 2006; 30: 1445 -53.
41. Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP,. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 2002; 15: 1044 -50.
42. Chen YY, Hwang ES, Roy R, DeVries S, Anderson J, Wa C, et al. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol 2009; 33: 1683 -94. PMCID: 2783988.
43. Simpson PT, Reis-Filho JS, Lambros MB, et al. Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 2008; 215: 231 -44.
44. Sapino A, Frigerio A, Peterse JL, Arisio R, Coluccia C, Bussolati G,. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch 2000; 436: 421 -30.
45. Bentz JS, Yassa N, Clayton F,. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod Pathol 1998; 11: 814 -22.
46. Weidner N, Semple JP,. Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 1992; 23: 1167 -71.
47. Buchanan CL, Flynn LW, Murray MP, et al. Is pleomorphic lobular carcinoma really a distinct clinical entity? J Surg Oncol 2008; 98: 314 -7.
48. Eusebi V, Magalhaes F, Azzopardi JG,. Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol 1992; 23: 655 -62.